Open AccessThe Molecular Basis of 5α-Reductase Type 2 Deficiency
Author(s) -
Rafael Loch Batista,
Berenice B. Mendonca
Publication year - 2022
Publication title -
sexual development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 44
eISSN - 1661-5433
pISSN - 1661-5425
DOI - 10.1159/000525119
Subject(s) - biology , genetics , disorders of sex development , dihydrotestosterone , exon , gene , endocrinology , androgen , hormone
The 5α-reductase type 2 enzyme catalyzes the conversion of testosterone into dihydrotestosterone, playing a crucial role in male development. This enzyme is encoded by the SRD5A2 gene, which maps to chromosome 2 (2p23), consists of 5 exons and 4 introns, and encodes a 254 amino acid protein. Disruptions in this gene are the molecular etiology of a subgroup of differences of sex development (DSD) in 46,XY patients. Affected individuals present a large range of external genitalia undervirilization, ranging from almost typically female external genitalia to predominantly typically male external genitalia with minimal undervirilization, including isolated micropenis. This is an updated review of the implication of the SRD5A2 gene in 5α-reductase type 2 enzyme deficiency. For that, we identified 451 cases from 48 countries of this particular 46,XY DSD from the literature with reported variants in the SRD5A2 gene. Herein, we present the SRD5A2 mutational profile, the SRD5A2 polymorphisms, and the functional studies related to SRD5A2 variants to detail the molecular etiology of this condition.